Literature DB >> 23639576

Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas.

L Guo1, S Q Tsai, N E Hardison, A H James, A A Motsinger-Reif, B Thames, E A Stone, C Deng, J A Piedrahita.   

Abstract

INTRODUCTION: This study focuses on the implementation of modulated modularity clustering (MMC) a new cluster algorithm for the identification of molecular signatures of preeclampsia and intrauterine growth restriction (IUGR), and the identification of affected microRNAs
METHODS: Eighty-six human placentas from normal (40), growth-restricted (27), and preeclamptic (19) term pregnancies were profiled using Illumina Human-6 Beadarrays. MMC was utilized to generate modules based on similarities in placental transcriptome. Gene Set Enrichment Analysis (GSEA) was used to predict affected microRNAs. Expression levels of these candidate microRNAs were investigated in seventy-one human term placentas as follows: control (29); IUGR (26); and preeclampsia (16).
RESULTS: MMC identified two modules, one representing IUGR placentas and one representing preeclamptic placentas. 326 differentially expressed genes in the module representing IUGR and 889 differentially expressed genes in a module representing preeclampsia were identified. Functional analysis of molecular signatures associated with IUGR identified P13K/AKT, mTOR, p70S6K, apoptosis and IGF-1 signaling as being affected. Analysis of variance of GSEA-predicted microRNAs indicated that miR-194 was significantly down-regulated both in preeclampsia (p = 0.0001) and IUGR (p = 0.0304), and miR-149 was significantly down-regulated in preeclampsia (p = 0.0168). DISCUSSION: Implementation of MMC, allowed identification of genes disregulated in IUGR and preeclampsia. The reliability of MMC was validated by comparing to previous linear modeling analysis of preeclamptic placentas.
CONCLUSION: MMC allowed the elucidation of a molecular signature associated with preeclampsia and a subset of IUGR samples. This allowed the identification of genes, pathways, and microRNAs affected in these diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23639576      PMCID: PMC3677766          DOI: 10.1016/j.placenta.2013.04.007

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  40 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  Latest advances in understanding preeclampsia.

Authors:  Christopher W Redman; Ian L Sargent
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

3.  Application of a priori established gene sets to discover biologically important differential expression in microarray data.

Authors:  Andrea Bild; Phillip George Febbo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

Review 4.  Pre-eclampsia.

Authors:  Baha Sibai; Gus Dekker; Michael Kupferminc
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

5.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

6.  Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?

Authors:  José Villar; Guillermo Carroli; Daniel Wojdyla; Edgardo Abalos; Daniel Giordano; Hassan Ba'aqeel; Ubaldo Farnot; Per Bergsjø; Leiv Bakketeig; Pisake Lumbiganon; Liana Campodónico; Yagob Al-Mazrou; Marshall Lindheimer; Michael Kramer
Journal:  Am J Obstet Gynecol       Date:  2006-04       Impact factor: 8.661

7.  Data mining in bioinformatics using Weka.

Authors:  Eibe Frank; Mark Hall; Len Trigg; Geoffrey Holmes; Ian H Witten
Journal:  Bioinformatics       Date:  2004-04-08       Impact factor: 6.937

8.  Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample.

Authors:  J G Millar; S K Campbell; J D Albano; B R Higgins; A D Clark
Journal:  Br J Obstet Gynaecol       Date:  1996-05

9.  Evi5 promotes collective cell migration through its Rab-GAP activity.

Authors:  Carl Laflamme; Gloria Assaker; Damien Ramel; Jonas F Dorn; Desmond She; Paul S Maddox; Gregory Emery
Journal:  J Cell Biol       Date:  2012-07-09       Impact factor: 10.539

10.  Characterization of EvaGreen and the implication of its physicochemical properties for qPCR applications.

Authors:  Fei Mao; Wai-Yee Leung; Xing Xin
Journal:  BMC Biotechnol       Date:  2007-11-09       Impact factor: 2.563

View more
  33 in total

Review 1.  The Function of TrophomiRs and Other MicroRNAs in the Human Placenta.

Authors:  Yoel Sadovsky; Jean-Francois Mouillet; Yingshi Ouyang; Avraham Bayer; Carolyn B Coyne
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

Review 2.  Maternal Circulating microRNAs and Pre-Eclampsia: Challenges for Diagnostic Potential.

Authors:  Malia S Q Murphy; Chandrakant Tayade; Graeme N Smith
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

Review 3.  MicroRNAs, immune cells and pregnancy.

Authors:  Mallikarjun Bidarimath; Kasra Khalaj; Jocelyn M Wessels; Chandrakant Tayade
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

Review 4.  MicroRNAs in placental health and disease.

Authors:  Jean-François Mouillet; Yingshi Ouyang; Carolyn B Coyne; Yoel Sadovsky
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

5.  Identification and Validation of a Five-Gene Diagnostic Signature for Preeclampsia.

Authors:  Yu Liu; Xiumin Lu; Yuhong Zhang; Meimei Liu
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

6.  MAGE: An Open-Source Tool for Meta-Analysis of Gene Expression Studies.

Authors:  Ioannis A Tamposis; Georgios A Manios; Theodosia Charitou; Konstantina E Vennou; Panagiota I Kontou; Pantelis G Bagos
Journal:  Biology (Basel)       Date:  2022-06-10

7.  Placental expression of miR-21-5p, miR-210-3p and miR-141-3p: relation to human fetoplacental growth.

Authors:  P Kochhar; P Dwarkanath; G Ravikumar; A Thomas; J Crasta; T Thomas; A V Kurpad; A Mukhopadhyay
Journal:  Eur J Clin Nutr       Date:  2021-10-05       Impact factor: 4.884

Review 8.  microRNA signatures associated with fetal growth restriction: a systematic review.

Authors:  P Kochhar; M Vukku; R Rajashekhar; A Mukhopadhyay
Journal:  Eur J Clin Nutr       Date:  2021-11-05       Impact factor: 4.884

9.  High-throughput miRNA sequencing of the human placenta: expression throughout gestation.

Authors:  Tania L Gonzalez; Laura E Eisman; Nikhil V Joshi; Amy E Flowers; Di Wu; Yizhou Wang; Chintda Santiskulvong; Jie Tang; Rae A Buttle; Erica Sauro; Ekaterina L Clark; Rosemarie DiPentino; Caroline A Jefferies; Jessica L Chan; Yayu Lin; Yazhen Zhu; Yalda Afshar; Hsian-Rong Tseng; Kent Taylor; John Williams; Margareta D Pisarska
Journal:  Epigenomics       Date:  2021-05-25       Impact factor: 4.778

10.  Placental microRNA expression associates with birthweight through control of adipokines: results from two independent cohorts.

Authors:  Elizabeth M Kennedy; Karen Hermetz; Amber Burt; Todd M Everson; Maya Deyssenroth; Ke Hao; Jia Chen; Margaret R Karagas; Dong Pei; Devin C Koestler; Carmen J Marsit
Journal:  Epigenetics       Date:  2020-10-04       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.